Julie Fields Liu

USPTO Granted Patents = 41 (Patent Applications = 35)

CIPO Patents = 3

EPO Patents = 14 (Patent Applications = 18)

Average Co-Inventor Count = 2.2

ph-index = 7

Forward Citations = 181(Granted Patents)

Company Filing History:

36 out of 136

Concert Pharmaceuticals, Inc.

patents

4 out of 850

Millennium Pharmaceuticals Limited

patents

1 out of 148

Sun Pharmaceutical Industries Limited

patents

Years Active: 2009-2024

Loading Chart...

41 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12029712 - Deuterated analogs of D-serine and uses thereof (2024-07-09),

2. 11267777 - Deuterated EPI-743 (2022-03-08),

3. 10683305 - Deuterated OTX-015 (2020-06-16),

4. 10668036 - Deuterated analogs of D-serine and uses thereof (2020-06-02),

5. 10335413 - Substituted xanthine derivatives (2019-07-02),

6. 10160778 - Pyrimidine phosphonic acid esters (2018-12-25),

7. 9944635 - Deuterated pyrazino[2,1-a]isoquinoline compounds and methods of treatment using the same (2018-04-17),

8. 9918987 - Substituted xanthine derivatives (2018-03-20),

9. 9493463 - Substituted xanthine derivatives (2016-11-15),

10. 9492457 - Substituted xanthine derivatives (2016-11-15),

11. 9453009 - Synthesis of deuterated morpholine derivatives (2016-09-27),

12. 9296689 - Substituted isoindoline-1,3-dione derivatives (2016-03-29),

13. 9273009 - Tetrahydronaphthalene derivatives (2016-03-01),

14. 9249149 - Deuterated derivatives of ruxolitinib (2016-02-02),

15. 9206179 - Methods of use comprising deuterated pyrazino[2,1-a]isoquinolines (2015-12-08),

Title: Julie Fields Liu: Pioneering Innovations in Pharmaceuticals

Introduction: Julie Fields Liu, a prominent inventor based in Lexington, MA, is renowned for her remarkable passion for innovation and unwavering dedication to excellence. With an impressive portfolio of 40 patents, Julie Fields Liu's groundbreaking inventions are shaping the future of technology and inspiring the next generation of inventors.

Latest Patents: Among her latest patents is the revolutionary Deuterated EPI-743, a novel α-tocotrienol quinone compound with significant pharmaceutical potential. Additionally, her Deuterated OTX-015 invention, focusing on thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepines, showcases her expertise in developing cutting-edge pharmaceutical compositions for treating various diseases.

Career Highlights: Julie Fields Liu's illustrious career includes pivotal roles at Concert Pharmaceuticals, Inc. and Millennium Pharmaceuticals Limited, where she spearheaded innovative research projects and contributed significantly to the advancement of pharmaceutical technology. Her expertise and leadership have been instrumental in driving groundbreaking developments in the industry.

Collaborations: Throughout her career, Julie Fields Liu has collaborated closely with esteemed professionals such as Scott L Harbeson and Roger D Tung, fostering a culture of innovation and collaboration. Her collaborative efforts have led to the successful implementation of novel ideas and the development of transformative inventions.

Conclusion: Julie Fields Liu's impact on the field of pharmaceutical innovation is truly remarkable. Her relentless pursuit of excellence, coupled with her visionary approach to problem-solving, continues to inspire and shape the landscape of technology. As a pioneering inventor, Julie Fields Liu's contributions will undoubtedly leave a lasting legacy in the world of innovation.

This text is generated by artificial intelligence and may not be accurate.